Negative remnant 99mTc-pertechnetate uptake predicts excellent response to radioactive iodine therapy in low- to intermediate-risk differentiated thyroid cancer patients who have undergone total thyroidectomy
- 1. China-Japan Union Hospital of Jilin University, Department of Nuclear Medicine (China)
Description
Objective
Negative 99mTc-pertechnetate uptake of the thyroid bed indicates the absence or a small volume of remnant thyroid tissue (RTT) after total thyroidectomy (TT). The aim of this study is to evaluate the predictive value of negative 99mTc-pertechnetate scintigraphy for excellent response (ER) to radioactive iodine therapy (RIT) in low- to intermediate-risk differentiated thyroid cancer (DTC) patients.Patients
One-hundred and eighty-nine low- to intermediate-risk DTC patients who underwent TT, RIT with a single dose of 30 mCi and suppressive therapy with thyroid-stimulating hormone (TSH) from July 2015 to February 2016 in our hospital were retrospectively evaluated. 99mTc-pertechnetate thyroid scintigraphy was performed just before RIT and images were reported dichotomously as negative or positive. The response of patients was assessed for 23.2 ± 3.8 months after RIT and dichotomized as excellent response (ER) or non-excellent response (NER). 99mTc-pertechnetate uptake, age at diagnosis, gender, multifocality, T stage, N stage, preablative stimulated thyroglobulin (ps-Tg), and TSH were explored as potential predictors for ER.
Results
80.68% (71/88) of patients with negative 99mTc-pertechnetate uptake achieved ER. When patients were evaluated according to different ps-Tg levels, we found that 94.83% (55/58) of patients with ps-Tg < 1 ng/ml and negative 99mTc-pertechnetate uptake achieved ER. Multivariate Cox regression analysis revealed that ps-Tg (P = 0.0001) and 99mTc-pertechnetate uptake (P = 0.0473) were independent predictors for ER.
Conclusions
In addition to ps-Tg, negative 99mTc-pertechnetate uptake is also a significant independent predictor for an excellent response in low- to intermediate-risk patients. It may be possible to omit RIT in patients with ps-Tg < 1 ng/ml and concurrent negative 99mTc-pertechnetate uptake.
Additional details
Identifiers
Publishing Information
- Journal Title
- Annals of Nuclear Medicine
- Journal Volume
- 33
- Journal Issue
- 2
- Journal Page Range
- p. 112-118
- ISSN
- 0914-7187
- CODEN
- ANMEEX
INIS
- Country of Publication
- Japan
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 54059955
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- BRACHYTHERAPY; DIAGNOSIS; IMAGES; IODINE; MULTIVARIATE ANALYSIS; PATIENTS; REGRESSION ANALYSIS; SCINTISCANNING; TECHNETIUM 99; THERAPEUTIC DOSES; THYROGLOBULIN; THYROID; TSH; UPTAKE
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; COUNTING TECHNIQUES; DIAGNOSTIC TECHNIQUES; DOSES; ELEMENTS; ENDOCRINE GLANDS; GLANDS; GLOBULINS; HALOGENS; HORMONES; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MATHEMATICS; MEDICINE; NONMETALS; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANS; PEPTIDE HORMONES; PITUITARY HORMONES; PROTEINS; RADIOISOTOPE SCANNING; RADIOISOTOPES; RADIOLOGY; RADIOTHERAPY; STATISTICS; TECHNETIUM ISOTOPES; THERAPY; YEARS LIVING RADIOISOTOPES
Optional Information
- Copyright
- Copyright (c) 2019 The Japanese Society of Nuclear Medicine